The NAHD program envisages to develop novel methods for gene therapy of hereditary blood disorders such as hemophilia, thalassemia and sickle cell disease.
Applications of iPSC Technology
The NAHD program intends to create a bank of cells from individuals with homozygous HLA haplotype called the “haplobank” with an aim to develop the field of cell therapy.
Thalassaemia and Sickle Cell Disease Control Program
Under the NAHD program, CSCR and CMC, Vellore have taken initiative to develop a model for community outreach program for the control of major haemoglobin disorders.